Alzheimers Disease: - Axonyx’ Alzheimer’s Candidate Appears Safe in Trial
Tuesday, January 31st, 2006Axonyx’ Alzheimer’s Candidate Appears Safe in TrialInternational News Service, Australia - Jan 29, 2006Axonyx’ investigational treatment for Alzheimer’s disease progression, Posiphen, has been shown to be well tolerated at single doses up to and including 80mg …
Tony Spaulding: ‘Trench Town Rock’Jamaica Gleaner, Jamaica - 14 hours ago… The former Member of Parliament and Minister of Housing, who suffered […]